⌘K

Home/Filings/4/0001213900-21-019678

4//SEC Filing

Bassan Merav 4

Accession 0001213900-21-019678

CIK 0001739174other

View on SEC.gov Company Profile

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 4:33 PM ET

Size

5.5 KB

Accession

0001213900-21-019678

Insider Transaction Report

Form 4

Period: 2021-03-30

Chief Development Officer

Transactions

Award
Common Stock Options - Right to Buy
2021-03-30+47,500→ 47,500 total
Exercise: $7.02Exp: 2031-03-30→ Common Stock (47,500 underlying)

Footnotes (1)

[F1]The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 30, 2022, and the remainder vesting in 12 equal quarterly installments over three years.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

BiomX Inc.

CIK 0001739174

Entity typeother

Related Parties

1

filerCIK 0001792702

Filing Metadata

Form type: 4
Filed: Mar 31, 8:00 PM ET
Accepted: Apr 1, 4:33 PM ET
Size: 5.5 KB

View on SEC.gov